U.S. Diabetes Devices Market Size & Outlook, 2023-2030
U.S. diabetes devices market, 2018-2030 (US$M)
Related Markets
U.S. diabetes devices market highlights
- The U.S. diabetes devices market generated a revenue of USD 9,532.8 million in 2023 and is expected to reach USD 15,217.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, insulin delivery devices was the largest revenue generating type in 2023.
- Insulin Delivery Devices is the most lucrative type segment registering the fastest growth during the forecast period.
Diabetes devices market data book summary
| Market revenue in 2023 | USD 9,532.8 million |
| Market revenue in 2030 | USD 15,217.7 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Insulin delivery devices |
| Fastest growing segment | Insulin Delivery Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices |
| Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.4% of the global diabetes devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. diabetes devices market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 15,217.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Devices Market Scope
Diabetes Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. diabetes devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the U.S. diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The favorable reimbursement scenario provides access to healthcare services to a large portion of the population. Subsequently, it creates a demand for cost effective and efficient diabetes devices. This also increases the need for cost-effective diabetes devices and the integration of digital health in the care delivery system. Hence, many companies are seeking U.S.
FDA approval to launch their products in the U.S. market. For instance, in January 2022, Insulet Corporation announced that it received clearance from the U.S. FDA for its Omnipod 5 Automated Insulin Delivery System for people with type 1 diabetes aged 6 and above.
Reasons to subscribe to U.S. diabetes devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. diabetes devices market databook
-
Our clientele includes a mix of diabetes devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. diabetes devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. diabetes devices market size, by type, 2018-2030 (US$M)
U.S. Diabetes Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
